VERDICT analysis for prostate MRI

Dr. Ashwin Singh Parihar sits down with to discuss how post-therapy Lutetium 177 PSMA SPECT CT may help predict overall survival in patients with metastatic castration resistant prostate cancer and shape future treatment decisions. Drawing from the ENZAPI trial, they explore quan ... Show More

Dr. Siddhant Dogra sits down with Dr. Su Hwan Kim to discuss how reader experience influences the performance and real world utility of large language models for brain MRI differential diagnosis. Together they explore AI assisted decision making, automation bias, radiology traini ... Show More

Dr. Reni Butler discusses career advice for early, mid, and late career radiologists, mentorship, and work life integration with Dr. Stamatia Destounis and Dr. Mark Mullins. This episode was first published Oct 10, 2023 

Prostate cancer diagnostic guidelines aim to minimize over-diagnosis of clinically insignificant prostate cancer (Gleason6/GG1). The clinical question before us is how do we enable the best balance, helping to increase compliance with the biopsy recommendation for patients at hig ... Show More

Biomarkers and Molecular Imaging for Prostate Cancer CME Available: auau.auanet.org/node/41727 ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Lantheus Medical Imaging Novartis Pharmaceuticals Corporation LEARNING OBJECTIVES: At the conclusion of this a ... Show More

New research on prostate cancer screening and diet. This episode features audio from: The Pros and Cons of Testing PSA Levels for Prostate Cancer Changing a Man’s Diet After a Prostate Cancer Diagnosis Natural Dietary Treatments for Enlarged Prostate BPH Visit the video pages for ... Show More

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer. 

We will discuss common PSA dilemmas: 1. Who should be screened? 2. What is the role of MRI in biopsy naive and men with prior negative biopsy? 3. What other markers can be used to determine whether biopsy or rebiopsy is warranted? 4. Whats the optimal biopsy strategy: Transrectal ... Show More

<p>Silke Gillessen and Chris Sweeney discuss how data from recent ESMO and GU ASCO meetings has changed the way they treat prostate cancer.&nbsp;</p> 

In this episode, we review the high-yield topic of Prostate Cancer from the Oncology section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets 

As the government calls for a ban on the sale of e cigarettes to under 18s, Dr Mark Porter is joined by Martin McKee, Gerard Hastings and Robert West to discuss who is using them and how they are being advertised. The chairman of NICE, David Haslam has suggested patients should d ... Show More

How are you managing your prostate cancer patients on active surveillance? Credit available for this activity expires: 5/25/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/992384?ecd=bdc_podcast_libsyn_mscpedu